Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00108_DB00352_nanopub.RAdpMqK9UlofaH7AAfvrn-apUKnBRP7ucYEZ4N6JJYg0U#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00108_DB00352 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00108_DB00352 label "DDI between Natalizumab and Tioguanine - The immunosuppressant, Thioguanine, may increase the adverse effects of Natalizumab. Increased risk of Progressive Multifocal Leukoencephalopathy (PML) and other infections. Concurrent therapy should be avoided. [drugbank_resource:DB00108_DB00352]" assertion.
- drugbank_resource:DB00108_DB00352 identifier "drugbank_resource:DB00108_DB00352" assertion.
- drugbank_resource:DB00108_DB00352 title "DDI between Natalizumab and Tioguanine - The immunosuppressant, Thioguanine, may increase the adverse effects of Natalizumab. Increased risk of Progressive Multifocal Leukoencephalopathy (PML) and other infections. Concurrent therapy should be avoided." assertion.
- drugbank:DB00108 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00108_DB00352 assertion.
- drugbank:DB00352 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00108_DB00352 assertion.